Radioimmunotherapy with an 211 At‐labeled anti–tissue factor antibody protected by sodium ascorbate-Reference-Cited by-同舟云学术

Radioimmunotherapy with an 211 At‐labeled anti–tissue factor antibody protected by sodium ascorbate

Published:2021-03-30 Issue:5 Volume:112 Page:1975-1986
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takashima Hiroki¹^ORCID,Koga Yoshikatsu¹²^ORCID,Manabe Shino³⁴⁵^ORCID,Ohnuki Kazunobu⁶,Tsumura Ryo¹^ORCID,Anzai Takahiro¹,Iwata Nozomi¹,Wang Yang⁷,Yokokita Takuya⁷,Komori Yukiko⁷,Mori Daiki⁷,Usuda Sachiko⁷,Haba Hiromitsu⁷,Fujii Hirofumi⁶,Matsumura Yasuhiro⁸,Yasunaga Masahiro¹^ORCID

Affiliation:

1. Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

2. Department of Strategic Programs, Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

3. Laboratory of Functional Molecule Chemistry, Pharmaceutical Department and Institute of Medicinal Chemistry Hoshi University Tokyo Japan

4. Research Center for Pharmaceutical Development, Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences Tohoku University Sendai Japan

5. Glycometabolic Biochemistry Laboratory RIKEN Wako Japan

6. Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

7. Nishina Center for Accelerator‐Based Science RIKEN Wako Japan

8. Department of Immune Medicine National Cancer Center Research Institute National Cancer Center Chuo‐ku, Tokyo Japan

Funder

Japan Agency for Medical Research and Development

National Cancer Center

RIKEN

Japan Society for the Promotion of Science

Publisher

Wiley

Subject